Bank Julius Baer & Co
ARCT icon

Bank Julius Baer & Co’s Arcturus Therapeutics ARCT Stock Holding History

Bank Julius Baer & Co’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.38K Hold
800
– – ﹤0.01% 642
2026
Q1 		$6.17K Hold
800
– – ﹤0.01% 656
2025
Q4 		$4.9K Hold
800
– – ﹤0.01% 626
2025
Q3 		$14.7K Sell
800
-1,500
-65% -$24.1K ﹤0.01% 633
2025
Q2 		$29.9K Hold
2,300
– – ﹤0.01% 568
2025
Q1 		$24.4K Buy
2,300
+216
+10% +$3.43K ﹤0.01% 571
2024
Q4 		$39K Sell
2,084
-23,201
-92% -$437K ﹤0.01% 575
2024
Q3 		$696K Sell
25,285
-1,971
-7% -$42.2K ﹤0.01% 309
2024
Q2 		$739K Sell
27,256
-16,506
-38% -$501K ﹤0.01% 255
2024
Q1 		$1.48M Sell
43,762
-3,470
-7% -$123K 0.01% 242
2023
Q4 		$1.49M Sell
47,232
-11,028
-19% -$262K 0.01% 253
2023
Q3 		$1.49M Sell
58,260
-1,569
-3% -$48.3K 0.01% 225
2023
Q2 		$1.72M Sell
59,829
-10,241
-15% -$279K 0.01% 226
2023
Q1 		$1.68M Buy
70,070
+3,746
+6% +$67.2K 0.01% 219
2022
Q4 		$1.13M Buy
66,324
+6,707
+11% +$117K 0.01% 251
2022
Q3 		$884K Sell
59,617
-65,221
-52% -$1.09M 0.01% 272
2022
Q2 		$1.97M Sell
124,838
-92,425
-43% -$1.81M 0.01% 209
2022
Q1 		$5.86M Sell
217,263
-48,907
-18% -$1.25M 0.04% 163
2021
Q4 		$9.85M Sell
266,170
-414,079
-61% -$16.9M 0.05% 154
2021
Q3 		$32.5M Sell
680,249
-22,529
-3% -$1.01M 0.2% 87
2021
Q2 		$23.8M Buy
702,778
+287,237
+69% +$9.72M 0.15% 114
2021
Q1 		$17.2M Buy
415,541
+79,464
+24% +$4.74M 0.13% 124
2020
Q4 		$14.6M Buy
336,077
+200,809
+148% +$13.6M 0.12% 121
2020
Q3 		$5.9M Buy
+135,268
New +$6.71M 0.06% 149

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bank Julius Baer & Co's ARCT Position: Q2 2026 in Review

Bank Julius Baer & Co held its Arcturus Therapeutics (ARCT) position steady in Q2 2026 at 800 shares worth $5.38K. The position accounts for ﹤0.01% of the portfolio, ranked #642.

Bank Julius Baer & Co first reported a position in ARCT in Q3 2020 and has held it in 24 quarters since. The position peaked at $32.5M in Q3 2021. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Bank Julius Baer & Co held 800 shares of Arcturus Therapeutics worth $5.38K as of Q2 2026.
  • Bank Julius Baer & Co left its Arcturus Therapeutics share count unchanged in Q2 2026.
  • Arcturus Therapeutics made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q2 2026, its #642 holding.
  • Bank Julius Baer & Co first reported a position in Arcturus Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • Bank Julius Baer & Co's Arcturus Therapeutics position peaked at $32.5M in Q3 2021.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Bank Julius Baer & Co's 13F filing for Q2 2026, filed 10 Aug 2026.